The distinctive nature of HER2-positive gastric cancers

被引：13
|
作者：
Marano, L. [1 ]
Roviello, F. [1 ]
机构：
[1] Univ Siena, Dept Med Surg & Neurosci, Unit Gen & Minimally Invas Surg, I-53100 Siena, Italy
来源：
EJSO | 2015年 / 41卷 / 03期
关键词：
HER2; EXPRESSION; RECEPTOR; PROTEIN;
D O I：
10.1016/j.ejso.2014.12.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：271 / 273
页数：3
相关论文
共 50 条
  • [31] Her2-Positive and Microsatellite Instability Status in Gastric Cancer-Clinicopathological Implications
    Bermudez, Ana
    Arranz-Salas, Isabel
    Mercado, Silvia
    Lopez-Villodres, Juan A.
    Gonzalez, Virginia
    Rius, Francisca
    Ortega, Maria V.
    Alba, Carmen
    Hierro, Isabel
    Bermudez, Diego
    DIAGNOSTICS, 2021, 11 (06)
  • [32] Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer
    Castagnoli, Lorenzo
    Corso, Simona
    Franceschini, Alma
    Raimondi, Alessandra
    Bellomo, Sara Erika
    Dugo, Matteo
    Morano, Federica
    Prisciandaro, Michele
    Brich, Silvia
    Belfiore, Antonino
    Vingiani, Andrea
    Di Bartolomeo, Maria
    Pruneri, Giancarlo
    Tagliabue, Elda
    Giordano, Silvia
    Pietrantonio, Filippo
    Pupa, Serenella M.
    CELLULAR ONCOLOGY, 2023, 46 (03) : 661 - 676
  • [33] Recent Progress in Treatment for HER2-Positive Advanced Gastric Cancer
    Kawakami, Takeshi
    Yamazaki, Kentaro
    CANCERS, 2024, 16 (09)
  • [34] Clinicopathological features and endoscopic findings of HER2-positive gastric cancer
    Yasuhiro Oono
    Takeshi Kuwata
    Kenji Takashima
    Yusuke Yoda
    Hiroaki Ikematsu
    Kohei Shitara
    Takahiro Kinoshita
    Tomonori Yano
    Surgical Endoscopy, 2018, 32 : 3964 - 3971
  • [35] Pertuzumab in HER2-positive breast cancer
    Sendur, Mehmet A. N.
    Aksoy, Sercan
    Altundag, Kadri
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (10) : 1709 - 1716
  • [36] Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
    Shitara, Kohei
    Bang, Yung-Jue
    Iwasa, Satoru
    Sugimoto, Naotoshi
    Ryu, Min-Hee
    Sakai, Daisuke
    Chung, Hyun-Cheol
    Kawakami, Hisato
    Yabusaki, Hiroshi
    Lee, Jeeyun
    Saito, Kaku
    Kawaguchi, Yoshinori
    Kamio, Takahiro
    Kojima, Akihito
    Sugihara, Masahiro
    Yamaguchi, Kensei
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25) : 2419 - 2430
  • [37] Trastuzumab in HER2-Positive Metastatic Gastric Cancer Profile Report
    Croxtall, Jamie D.
    McKeage, Kate
    BIODRUGS, 2011, 25 (04) : 257 - 259
  • [38] HER2-Positive Gastroesophageal Cancers Are Associated with a Higher Risk of Brain Metastasis
    Tincknell, Gary
    Naveed, Asma
    Nankervis, Jane
    Mukhtiar, Ayesha
    Piper, Ann-Katrin
    Becker, Therese M. M.
    Chantrill, Lorraine
    Aghmesheh, Morteza
    Vine, Kara Lea
    Ranson, Marie
    Brungs, Daniel
    CANCERS, 2022, 14 (23)
  • [39] Tailoring DNA vaccines: designing strategies against HER2-positive cancers
    Marchini, Cristina
    Kalogris, Cristina
    Garulli, Chiara
    Pietrella, Lucia
    Gabrielli, Federico
    Curcio, Claudia
    Quaglino, Elena
    Cavallo, Federica
    Amici, Augusto
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [40] Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan
    Pourjamal, Negar
    Le Joncour, Vadim
    Vereb, Gyorgy
    Honkamaki, Cilla
    Isola, Jorma
    Leyton, Jeffrey, V
    Laakkonen, Pirjo
    Joensuu, Heikki
    Barok, Mark
    TRANSLATIONAL ONCOLOGY, 2025, 53
12345